CG Invites Co., Ltd. (KOSDAQ:083790)
South Korea · Delayed Price · Currency is KRW 989.00
-17.00 (-1.69%)
Jul 1, 2026, 9:30 AM KST
CG Invites Market Cap
CG Invites has a market cap or net worth of 77.36 billion as of June 30, 2026. Its market cap has decreased by -49.95% in one year.
Market Cap
77.36B
Enterprise Value
129.04B
Revenue
29.22B
Ranking
n/a
PE Ratio
n/a
Stock Price
989.00
Market Cap Chart
Since January 6, 2006, CG Invites's market cap has decreased from 137.39B to 77.36B, a decrease of -43.70%. That is a compound annual growth rate of -2.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2026 | 77.36B | -32.35% |
| Dec 30, 2025 | 114.34B | -38.17% |
| Dec 30, 2024 | 184.93B | -11.21% |
| Dec 28, 2023 | 208.28B | -13.64% |
| Dec 29, 2022 | 241.17B | -46.50% |
| Dec 30, 2021 | 450.79B | -45.11% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Macrogen | 126.74B |
| NeoImmuneTech | 124.57B |
| Genexine | 104.60B |
| Amicogen | 103.28B |
| MedPacto | 96.31B |
| Vaxcell-Bio Therapeutics | 92.10B |
| ENCell | 78.20B |
| iNtRON Biotechnology | 74.77B |